Search research articles
Contact Us
Filters
Showing results (521-530 of 692) with videos related to
Page
of 70
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2007
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy
David B Agus, Christopher J Sweeney, Michael J Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Pharmacokinetics and toxicity of weekly docetaxel in older patients
Arti Hurria, Mark T Fleming, Sharyn D Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
David B Solit, S Percy Ivy, Catherine Kopil, et al.
Cancer Cell
|
December 30, 2014
Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ
Sarit Schwartz, John Wongvipat, Cath B Trigwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 11, 2012
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors
Margaret M Centenera, Joanna L Gillis, Adrienne R Hanson, et al.
Annals of Neurology
|
December 21, 2005
Migraine and MTHFR C677T genotype in a population-based sample
Ann I Scher, Gisela M Terwindt, W M Monique Verschuren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2015
Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer
Howard I Scher, Glenn Heller, Arturo Molina, et al.
JAMA Oncology
|
March 10, 2018
Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial
Dana E Rathkopf, Tomasz M Beer, Yohann Loriot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 2022
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER
Anthony M Joshua, Andrew Armstrong, Megan Crumbaker, et al.
Cancer Cell
|
July 23, 2019
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Wenjing Su, Hyun Ho Han, Yan Wang, et al.
Page
of 70
Search research articles
Search
Showing results (521-530 of 692) with videos related to
Sort By:
Page
of 70
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 2007
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy
David B Agus, Christopher J Sweeney, Michael J Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Pharmacokinetics and toxicity of weekly docetaxel in older patients
Arti Hurria, Mark T Fleming, Sharyn D Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
David B Solit, S Percy Ivy, Catherine Kopil, et al.
Cancer Cell
|
December 30, 2014
Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ
Sarit Schwartz, John Wongvipat, Cath B Trigwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 11, 2012
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors
Margaret M Centenera, Joanna L Gillis, Adrienne R Hanson, et al.
Annals of Neurology
|
December 21, 2005
Migraine and MTHFR C677T genotype in a population-based sample
Ann I Scher, Gisela M Terwindt, W M Monique Verschuren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2015
Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer
Howard I Scher, Glenn Heller, Arturo Molina, et al.
JAMA Oncology
|
March 10, 2018
Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial
Dana E Rathkopf, Tomasz M Beer, Yohann Loriot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 2022
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER
Anthony M Joshua, Andrew Armstrong, Megan Crumbaker, et al.
Cancer Cell
|
July 23, 2019
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Wenjing Su, Hyun Ho Han, Yan Wang, et al.
Page
of 70